表紙:抗炎症薬市場 - 市場規模、シェア、見通し、機会分析:2020年~2027年
市場調査レポート
商品コード
980011

抗炎症薬市場 - 市場規模、シェア、見通し、機会分析:2020年~2027年

Anti-inflammatory Drugs Market, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 200 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
抗炎症薬市場 - 市場規模、シェア、見通し、機会分析:2020年~2027年
出版日: 2020年12月23日
発行: Coherent Market Insights
ページ情報: 英文 200 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の抗炎症薬市場は、関節炎などの急性/慢性疾患の発生率の上昇が、市場の成長を促進すると予想されます。

当レポートでは、世界の抗炎症薬市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 調査目的と前提条件

第2章 市場範囲

第3章 市場力学・規制・動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • パイプライン分析
  • 償還シナリオ
  • 疫学
  • PEST分析
  • 規制シナリオ
  • 新製品の発売
  • コラボレーションと契約
  • 市場動向

第4章 世界の抗炎症薬市場:COVID-19パンデミックの影響

  • COVID-19市場シナリオ
  • 抗炎症薬製品市場に対するCOVID-19の影響

第5章 世界の抗炎症薬市場:薬剤の種類別

  • イントロダクション
  • 非ステロイド性抗炎症薬 (NSAID)
  • 免疫選択的抗炎症誘導体 (ImSAID)
  • 抗炎症生物製剤
  • コルチコステロイド

第6章 世界の抗炎症薬市場:適応別

  • イントロダクション
  • 関節炎
  • 慢性閉塞性肺疾患 (COPD)
  • 多発性硬化症
  • 炎症性腸疾患 (IBD)
  • 痛風
  • その他

第7章 世界の抗炎症薬市場:投与経路別

  • イントロダクション
  • 経口
  • 局所
  • 注射
  • 吸入

第8章 世界の抗炎症薬市場:流通チャネル別

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 世界の抗炎症薬市場:地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第10章 競合情勢

  • ヒートマップ分析
  • 市場シェア分析
    • Pfizer, Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson Services Inc.
    • Merck & Company, Inc.
    • Novartis AG
    • Amgen, Inc.
    • AstraZeneca plc
    • Eli Lily and Company
    • AbbVie Inc.
    • F. Hoffmann-La Roche AG
    • Bristol Myers Squibb Company
    • Biogen Inc.
    • Sun Pharmaceutical Industries Ltd
    • Mylan, Inc.
    • Aurobindo Pharma Limited
    • Dr. Reddy's Laboratories
    • アナリストの見解

第11章 セクション

目次

Title:
Anti-inflammatory Drugs Market, by Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives (ImSAIDs), Anti-inflammatory Biologics, and Corticosteroids), by Application (Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Gout, and Others), by Route of Administration (Oral, Topical, Injection, and Inhalation), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Anti-inflammatory drugs are used in the treatment of acute and chronic diseases with inflammatory etiology. Therapeutic delivery of anti-inflammatory drugs to the target site of action and simultaneously avoiding undesired side effects. Anti-inflammatory drug supports to improve the quality of life and management of several rheumatic conditions such as arthritis. Anti-inflammatory drugs, especially the non-steroidal forms has significant role in medical practice, which has strong potential to boost the market growth in the near future.

Market Dynamics

Rising incidence of acute and chronic diseases such as arthritis is expected to drive anti-inflammatory drugs market growth. For instance, according to an article published by the Morbidity and Mortality Weekly Report, an epidemiological digest Centers for Disease Control and Prevention (CDC) in 2017, reports that arthritis affects over 1 in 4 adults and in rural areas in the U.S., 1 in 3 adults has arthritis.

However, side effects of anti-inflammatory drugs are expected to hinder the market growth. For instance, according to an article published by the healthdirect, Australia in January 2020, reports that the anti-inflammatory medicines may also trigger asthma in some people. The same source also states that children under 16 years must not be prescribed aspirin due to the rare occurrence of Reye's syndrome, which is potentially fatal.

Key features of the study:

  • This report provides in-depth analysis of the global anti-inflammatory drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global anti-inflammatory drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy's Laboratories among others
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global anti-inflammatory drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-inflammatory drugs market.

Detailed Segmentation:

  • Global Anti-inflammatory Drugs Market, By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
  • Global Anti-inflammatory Drugs Market, By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
  • Global Anti-inflammatory Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
  • Global Anti-inflammatory Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Anti-inflammatory Drugs Market, By Region:
    • North America
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Drug Type:
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Anti-inflammatory Biologics
      • Corticosteroids
      • By Application:
      • Arthritis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Multiple Sclerosis
      • Inflammatory Bowel Disease (IBD)
      • Gout
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Injection
      • Inhalation
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Pfizer, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • GlaxoSmithKline plc
    • Johnson & Johnson Services Inc.
    • Merck & Company, Inc.
    • Novartis AG
    • Amgen, Inc.
    • AstraZeneca plc
    • Eli Lily and Company
    • AbbVie Inc.
    • F. Hoffmann-La Roche AG
    • Bristol Myers Squibb Company
    • Biogen Inc.
    • Sun Pharmaceutical Industries Ltd
    • Mylan, Inc.
    • Aurobindo Pharma Limited
    • Dr. Reddy's Laboratories

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Application
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Anti-inflammatory Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Anti-inflammatory Drugs Products

5. Global Anti-inflammatory Drugs Market, By Drug Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Anti-inflammatory Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Anti-inflammatory Drugs Market, By Application, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Chronic Obstructive Pulmonary Disease (COPD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Multiple Sclerosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Inflammatory Bowel Disease (IBD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Gout
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Inhalation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

9. Global Anti-inflammatory Drugs Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson Services Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Company, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Amgen, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lily and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Biogen Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sun Pharmaceutical Industries Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mylan, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aurobindo Pharma Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact